Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice

British Journal of Cancer

Volumn 79, Issue 9-10, 1999, Pages 1399-1405

  Hull, M A ^a,b   Booth, J K ^b   Tisbury, A ^a   Scott, N ^b   Bonifer, C ^a   Markham, A F ^a   Coletta, P L ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Adenoma; Cyclooxygenase; Immunohistochemistry; Macrophage; Min mouse; Prostaglandin

Indexed keywords

CYCLOOXYGENASE 2;

ADENOMA; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM; LAMINA PROPRIA; LARGE INTESTINE TUMOR; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE TUMOR;

EID: 0033050468     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690224     Document Type: Article

References (40)

1. Austyn JM and Gordon S (1981) F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 11: 805-815
2. Boolbol SK, Dannenberg AJ, Chadburn A, Martucci C, Guo X, Ramonetti JT, Abreu-Goris M, Newmark HL, Lipkin ML, DeCosse JJ and Bertagnolli MM (1996) Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 56: 2556-2560
3. Chiu C-H, McEntee MF and Whelan J (1997) Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis. Cancer Res 57: 4267-4273
4. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, Borenstein N and Dove W (1993) Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75: 631-639
5. DuBois RN, Gupta R, Brockman J, Reddy BS, Krakow SL and Lazar MA (1998) The nuclear eicosanoid receptor, PPARγ, is aberrantly expressed in colonic cancers. Carcinogenesis 19: 49-53
6. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S and DuBois RN (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188
7. Gustafson-Svard C, Lilja I, Hallbook O and Sjodahl R (1996) Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats. Gut 38: 79-84
8. Hume DA, Perry VH and Gordon S (1984) The mononuclear phagocyte system of the mouse defined by immunohistochemical localisation of antigen F4/80: macrophages associated with epithelia. Anat Record 210: 503-512
9. Mm mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res 56: 710-714
10. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA and Jothy S (1995) Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 55: 2556-2559
11. Kargman S, Charleson S, Cartwright M, Frank J, Riendeau D, Mancini J, Evans J and O'Neill G (1996) Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology III: 445-454
12. Kawamori T, Rao CV, Seibert K and Reddy BS (1998) Chemopreventative activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58: 409-412
13. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83: 813-819
14. Kutchera W, Jones DA, Matsunami N, Groden J, McIntyre TM, Zimmerman GA, White RL and Prescott SM (1996) Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc Natl Acad Sci USA 93: 4816-4820
15. Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, Liou S, Simmons D and Hwang D (1992) Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 267: 25934-25938
16. Levy GN (1997) Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer. FASEB J 11: 234-247
17. Levy DB, Smith KJ, Beazer-Barclay Y, Hamilton SR, Vogelstein B and Kinzler KW (1994) Inactivation of both APC alleles in human and mouse tumors. Cancer Res 54: 5953-5958
18. + in intestinal adenomas from Min mice. Cancer Res 54: 5947-5952
19. Min-induced intestinal neoplasia. Cell 81: 957-966
20. Mahmoud NN, Boolbol SK, Bilinski RT, Martucci C, Chadburn A and Bertagnolli MM (1997) Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration. Cancer Res 57: 5045-5050
21. 2 by murine macrophage cell lines. Prostaglandins 30: 949-967
22. Mills SJ, Shepherd NA, Hall PA, Hastings A, Mathers JC and Gunn A (1995) Proliferative compartment deregulation in the non-neoplastic colonic epithelium of familial adenomatous polyposis. Gut 36: 391-394
23. Moser AR, Pitot HC and Dove WF (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247: 322-324
24. Moser AR, Dove WF, Roth KA and Gordon JI (1992) The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J Cell Biol 116: 1517-1526
25. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge P, Markham A, Krush AJ, Petersen G, Hamilton SR, Nilbert MC, Levy DB, Bryan TM, Preisinger AC, Smith KJ, Su L-K, Kinzler KW and Vogelstein B (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253: 665-669
26. Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C and Taketo M (1995) Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci USA 92: 4482-4486
27. A716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803-809
28. Otto JC and Smith WL (1994) The orientation of prostaglandin endoperoxide synthases-1 and -2 in the endoplasmic reticulum. J Biol Chem 269: 19868-19875
29. Prescott SM and White RL (1996) Self-promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell 87: 783-786
30. Qiao L, Kozoni V, Tsioulias GJ, Koutsos MI, Hanif R, Shiff SJ and Rigas B (1995) Selected cicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochim Biophys Acta 258: 215-223
31. Regier MK, DeWitt DL, Schindler MS and Smith WL (1993) Subcellular localization of prostaglandin endoperoxide synthase-2 in murine 3T3 cells. Arch Biochem Biophys 301: 439-444
32. Rigas B, Goldman IS and Levine L (1993) Altered eicosanoid levels in human colon cancer. J Lab Clin Med 122: 518-523
33. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, Kimura S, Kato H, Kondo M and Hla T (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55: 3785-3789
34. Singh J, Hamid R and Reddy BS (1997) Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res 57: 3465-3470
35. Soesatyo M, Biewenga J, Kraal G and Sminia T (1990) The localization of macrophage subsets and dendritic cells in the gastrointestinal tract of the mouse with special reference to the presence of high endothelial venules. Cell Tissue Res 259: 587-593
36. Su L-K, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C, Gould KA and Dove WF (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668-670
37. Tsuji M and DuBois RN (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83: 493-501
38. Weiss HA and Forman D (1996) Aspirin, non-steroidal anti-inflammatory drugs and protection from colorectal cancer: a review of the epidemiological evidence. Scand J Gastroenterol 31 (suppl. 220): 137-141
39. Williams CS, Luongo C, Radhika A, Zhang T, Lamps LW, Nanney LB, Beauchamp RD and DuBois RN (1996) Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology 111: 1134-1140
40. Williams CS, Smalley W and DuBois RN (1997) Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invest 100: 1325-1329